Skip to main content

Table 2 Clinical outcomes of the strategy for managing DOR according to patient’s age compared between fresh M-II oocytes and accumulation of vitrified M-II oocytes

From: The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study

 

 < 35

35–37

38–40

 > 40

 

Accu

Fresh

p

Accu

Fresh

p

Accu

Fresh

p

Accu

Fresh

p

Number of patients

28

36

 

38

55

 

57

74

 

88

64

 

Number of OPU

117

36

 

192

55

 

301

74

 

519

64

 

OPU /patient Mean (SD)

4.18 (2.13)

1

 < 0.001*

5.05 (2.68)

1

 < 0.001*

5.28 (2.32)

1

 < 0.001*

5.91 (2.97)

1

 < 0.001*

Age at ART start (y), mean (SD)

31.89 (2.11)

31.86 (2.21)

0.954

36.03 (0.79)

36.09 (0.78)

0.696

39.11 (0.75)

38.84 (0.81)

0.055

43.17 (1.90)

42.36 (1.60)

0.01*

M-II oocytes /patient Mean (SD)

8.50 (3.92)

3.64 (1.44)

 < 0.001*

10.26 (5.33)

3.91 (1.34)

 < 0.001*

10.00 (4.32)

3.64 (1.67)

 < 0.001*

10.12 (5.03)

3.03 (1.62)

 < 0.001*

Fertilization of fresh survival or M-II % (SD)

77.08 (22.51)

74.26 (24.00)

0.633

75.07 (16.25)

77.03 (22.16)

0.643

74.51 (24.18)

74.85 (23.64)

0.936

75.05 (20.37)

74.90 (28.54)

0.968

Number of fresh ET

28

36

 

38

55

 

57

74

 

88

64

 

Embryos transferred Mean (SD)

2.18 (0.82)

1.81 (0.58)

0.037*

2.58 (0.89)

2.33 (0.67)

0.123

3.02 (0.9)

2.27 (0.96)

 < 0.001*

3.33 (0.85)

2.00 (0.99)

 < 0.001

Pregnancy /ET (%)

10(35.7)

16(44.4)

0.481

18(47.4)

26(47.3)

0.993

16(28.1)

23(31.1)

0.709

14(15.9)

6(9.4)

0.239

Implantation rate % (SD)

25.00 (39.93)

30.56 (38.32)

0.574

24.78 (32.68)

26.67 (32.01)

0.782

12.28 (21.08)

15.43 (27.12)

0.471

4.55 (10.64)

4.56 (16.19)

0.996

Miscarriage /ET (%)

1(10.0)

1(6.2)

1.000

6(33.3)

2(7.7)

0.048*

9(56.2)

4(17.4)

0.011*

8(57.1)

3(50.0)

1.000

Live birth /ET (%)

8(28.6)

15(41.7)

0.279

11(28.9)

23(41.8)

0.205

7(12.3)

19(25.7)

0.057

6(6.8)

3(4.7)

0.735

Number of surplus vitrified embryo

37

16

 

85

19

 

65

17

 

61

3

 

Surplus vitrified embryo /patient Mean (SD)

1.32 (1.83)

0.44 (0.73)

0.011*

2.24 (2.60)

0.35 (0.73)

 < 0.001*

1.14 (1.44)

0.23 (0.75)

 < 0.001*

0.69 (1.36)

0.05 (0.28)

0.001*

Cumulative live birth /ITT (%)

13(46.4)

16(44.4)

0.874

15(39.5)

24(43.6)

0.689

8(14.0)

20(27.0)

0.072

7(8.0)

3(4.7)

0.520

Cumulative live birth /OPU (%)

13(11.1)

16(44.4)

 < 0.001*

15(7.8)

24(43.6)

 < 0.001*

8(2.7)

20(27.0)

 < 0.001*

7(1.3)

3(4.7)

0.086

  1. Data are mean ± standard deviation or n (%) and compared among groups using Student’s t-test, chi-square test, or Fisher’s test for P-value. Abbreviations: Accu accumulation of vitrified oocytes; fresh = Fresh oocytes; DOR diminished ovarian reserve, OPU ovum pick-up, ART assisted reproduction technology, M-II metaphase II, ET embryo transfer, ITT intention to treat
  2. * p < 0.05